Herr Univ. Prof. Dr. med. Georg Heß
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail sendenin Aktivierung
Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B)
